Hai-Jiang Zhang1, Yi-Qiao Xing1, Wei Jin1, Dai Li2, Kaili Wu2, Yi Lu3. 1. Department of Ophthalmology, Renmin Hospital of Wuhan University Wuhan, China. 2. Department of Ophthalmology, Hubei University of Science and Technology Xianning, China ; China State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University Guangzhou, China. 3. Affiliated Hospital, Hubei Three Gorges Polytechnic Yichang, China.
Abstract
OBJECTIVE: This study aimed to investigate the effect of curcumin on the retinal structure and the expressions of interleukin-23 (IL-23) and IL-17 in the rat retina after retinal ischemia-reperfusion injury (RIRI). METHODS: 150 Sprague-Dawley rats were randomly divided into RIRI group (MG), low-dose curcumin group (LDCG) and high-dose curcumin group (HDCG), (n = 50 per group). RIRI was generated by anterior chamber perfusion of normal saline to the right eye. The left eye served as a normal control group (NCG). Rats in LDCG and HDCG received an intraperitoneal injection of 20 mg/kg/d and 100 mg/kg/d curcumin respectively, at 30 min before RIRI and once daily after RIRI. RESULTS: The morphological changes in HDCG group were improved as compared to MG and LDCG groups. Immunohistochemistry showed that IL-23 and IL-17 were mainly expressed in the ganglion cell layer and the inner nuclear layer of the retina. Low IL-23 and IL-17 expressions were observed in NCG, but increased significantly in MG and LDCG groups. Western blot assay and ELISA also showed that IL-23 and IL-17 expressions increased significantly after RIRI (vs. NCG, P<0.01). Moreover, the IL-23 expression reached a peak at 24 h, whereas IL-17 expression peaked at 72 h after RIRI. Curcumin reduced IL-23 and IL-17 expressions significantly in a dose-dependent manner (vs. MG, P<0.01). CONCLUSION: The IL-23 and IL-17 expressions increase after RIRI and curcumin significantly reduces retinal IL-23 and IL-17 expressions in a dose-dependent manner and is able to prevent the RIRI induced damage to the retina.
OBJECTIVE: This study aimed to investigate the effect of curcumin on the retinal structure and the expressions of interleukin-23 (IL-23) and IL-17 in the rat retina after retinal ischemia-reperfusion injury (RIRI). METHODS: 150 Sprague-Dawley rats were randomly divided into RIRI group (MG), low-dose curcumin group (LDCG) and high-dose curcumin group (HDCG), (n = 50 per group). RIRI was generated by anterior chamber perfusion of normal saline to the right eye. The left eye served as a normal control group (NCG). Rats in LDCG and HDCG received an intraperitoneal injection of 20 mg/kg/d and 100 mg/kg/d curcumin respectively, at 30 min before RIRI and once daily after RIRI. RESULTS: The morphological changes in HDCG group were improved as compared to MG and LDCG groups. Immunohistochemistry showed that IL-23 and IL-17 were mainly expressed in the ganglion cell layer and the inner nuclear layer of the retina. Low IL-23 and IL-17 expressions were observed in NCG, but increased significantly in MG and LDCG groups. Western blot assay and ELISA also showed that IL-23 and IL-17 expressions increased significantly after RIRI (vs. NCG, P<0.01). Moreover, the IL-23 expression reached a peak at 24 h, whereas IL-17 expression peaked at 72 h after RIRI. Curcumin reduced IL-23 and IL-17 expressions significantly in a dose-dependent manner (vs. MG, P<0.01). CONCLUSION: The IL-23 and IL-17 expressions increase after RIRI and curcumin significantly reduces retinal IL-23 and IL-17 expressions in a dose-dependent manner and is able to prevent the RIRI induced damage to the retina.
Authors: H L Li; N Kostulas; Y M Huang; B G Xiao; P van der Meide; V Kostulas; V Giedraitas; H Link Journal: J Neuroimmunol Date: 2001-05-01 Impact factor: 3.478
Authors: Ping Huang; Yanjiao Huo; Lucy X Lou; Hong Li; Colin J Barnstable; Chun Zhang; Samuel S Zhang Journal: Exp Eye Res Date: 2013-06-20 Impact factor: 3.467
Authors: Daniel López-Malo; Carlos Alberto Villarón-Casares; Jorge Alarcón-Jiménez; Maria Miranda; Manuel Díaz-Llopis; Francisco J Romero; Vincent M Villar Journal: Antioxidants (Basel) Date: 2020-01-06
Authors: Jacqueline V Lara-Espinosa; María Fernanda Arce-Aceves; Manuel O López-Torres; Vasti Lozano-Ordaz; Dulce Mata-Espinosa; Jorge Barrios-Payán; Carlos Alfredo Silva-Islas; Perla D Maldonado; Brenda Marquina-Castillo; Rogelio Hernández-Pando Journal: Int J Mol Sci Date: 2022-02-10 Impact factor: 5.923